Latest period
$152.37M
YoY change
-22.8%
5Y CAGR
+46.8%
Peak year (2024)
$217.19M
Latest annual
$167.74M
Total Assets history chart for Climb Bio (CLYM) from 2019 to 2025
Latest: $167.74M
Total Assets growth chart for Climb Bio (CLYM) from 2019 to 2025
Latest: -22.8%
Total Assets history table for Climb Bio (CLYM) from 2019 to 2025
| 2025 | $167.74M | -22.8% | −$49.44M | ||
| 2024 | $217.19M | +96.6% | +$106.72M | ||
| 2023 | $110.47M | -18.2% | −$24.52M | ||
| 2022 | $134.99M | -22.1% | −$38.25M | ||
| 2021 | $173.24M | +603.3% | +$148.61M | ||
| 2020 | $24.63M | +15.1% | +$3.24M | ||
| 2019 | $21.39M | — | — |
- 2025$167.74M-22.8%
- 2024$217.19M+96.6%
- 2023$110.47M-18.2%
- 2022$134.99M-22.1%
- 2021$173.24M+603.3%
- 2020$24.63M+15.1%
- 2019$21.39M—
Total Assets values are taken from Climb Bio's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Climb Bio (CLYM)
According to Climb Bio's latest reported financial statements, the company's latest reported total assets is $152.37M. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Climb Bio (CLYM) total assets totalled $167.74M – declined 22.8% year-over-year.
Climb Bio total assets has grown on net over the period, with a +46.8% compound annual growth rate over 2020–2025 (5 years).
Climb Bio total assets peaked at $217.19M in 2024; the latest annual figure is $167.74M in 2025 (22.8% below peak).
The record annual total assets stands at $217.19M, reached in 2024; the historical low of $21.39M was recorded in 2019.
Climb Bio Total Assets by Year
Climb Bio Total Assets 2025: $167.74M
Climb Bio posted total assets of $167.74M in 2025, declined 22.8% below 2024.
Climb Bio Total Assets 2024: $217.19M
In 2024, Climb Bio reported total assets of $217.19M, surged 96.6% from 2023. This figure represents the highest annual value in the available history.
Climb Bio Total Assets 2023: $110.47M
Climb Bio total assets in 2023 was $110.47M, declined 18.2% below 2022.
Climb Bio Total Assets 2022: $134.99M
2022's total assets for Climb Bio came in at $134.99M, declined 22.1% below 2021.
Climb Bio Total Assets 2021: $173.24M
Climb Bio total assets in 2021 was $173.24M.
See more financial history for Climb Bio (CLYM).
Sector peers by Total Assets
Healthcare peers of Climb Bio (CLYM), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation